Literature DB >> 15112976

Electronystagmographic findings in benign paroxysmal positional vertigo.

Stavros G Korres1, Dimitrios G Balatsouras, Eleftherios Ferekidis.   

Abstract

The aim of this study was to investigate the electronystagmographic findings in patients with benign paroxysmal positional vertigo. A retrospective review of the records of 168 patients with this disease during the past 3 years was performed. Epidemiological data and results from the audiological and neuro-otologic workup, including electronystagmography, were recorded. One hundred fifty-one patients had involvement of the posterior canal, 14 of the horizontal canal, and 3 of the anterior canal. Seventy-two patients (42.8%) had abnormal findings on the caloric tests. Thirty-seven of them (22%) had canal paresis and 23 (13.7%) had directional preponderance, whereas in 12 patients (7.1%) both unilateral weakness and directional preponderance were found. Finally, 21 patients (12.5%) had spontaneous nystagmus. It may be thus concluded that electronystagmographic abnormalities are quite common in patients with benign paroxysmal positional vertigo. Their presence may be explained according to several mechanisms, which are further discussed herein.

Entities:  

Mesh:

Year:  2004        PMID: 15112976     DOI: 10.1177/000348940411300411

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  11 in total

1.  Benign paroxysmal positional vertigo secondary to vestibular neuritis.

Authors:  Dimitrios G Balatsouras; George Koukoutsis; Panayotis Ganelis; Nicolas C Economou; Antonis Moukos; Andreas Aspris; Michael Katotomichelakis
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-11       Impact factor: 2.503

2.  Epidemiology of benign paroxysmal positional vertigo: a population based study.

Authors:  M von Brevern; A Radtke; F Lezius; M Feldmann; T Ziese; T Lempert; H Neuhauser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-29       Impact factor: 10.154

3.  Influence of cochlear implantation on the vestibular function.

Authors:  Eirini Katsiari; Dimitrios G Balatsouras; John Sengas; Maria Riga; George S Korres; John Xenelis
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-04-06       Impact factor: 2.503

4.  Vestibular evoked myogenic potentials in patients with BPPV.

Authors:  Stavros Korres; Eleni Gkoritsa; Dimitra Giannakakou-Razelou; Ioannis Yiotakis; Maria Riga; Thomas P Nikolpoulos
Journal:  Med Sci Monit       Date:  2011-01

5.  Inner ear disease and benign paroxysmal positional vertigo: a critical review of incidence, clinical characteristics, and management.

Authors:  M Riga; A Bibas; J Xenellis; S Korres
Journal:  Int J Otolaryngol       Date:  2011-08-02

6.  Vestibular evoked myogenic potentials and digital vectoelectro-nystagmography's study in patients with benign paroxysmal positional vertigo.

Authors:  Marta Maria da Silva Lira-Batista; Ricardo Schaffeln Dorigueto; Cristina Freitas Ganança
Journal:  Int Arch Otorhinolaryngol       Date:  2013-04

7.  Contribution of Vestibular-Evoked Myogenic Potential (VEMP) testing in the assessment and the differential diagnosis of otosclerosis.

Authors:  Ourania Tramontani; Eleni Gkoritsa; Eleftherios Ferekidis; Stavros G Korres
Journal:  Med Sci Monit       Date:  2014-02-07

Review 8.  Benign paroxysmal positional vertigo in the elderly: current insights.

Authors:  D G Balatsouras; G Koukoutsis; A Fassolis; A Moukos; A Apris
Journal:  Clin Interv Aging       Date:  2018-11-05       Impact factor: 4.458

9.  Elevated serum macrophage migration inhibitory factor levels correlate with benign paroxysmal positional vertigo and recurrence events.

Authors:  Hong-Bin Cai; Lei Duan; Ting Tian; Zi-Chao Li; Chong-Chong Zhao; Zhao-Ming Ge
Journal:  Biosci Rep       Date:  2019-08-23       Impact factor: 3.840

10.  Comparison of the effectiveness of Brandt-Daroff Vestibular training and Epley Canalith repositioning maneuver in benign Paroxysmal positional vertigo long term result: A randomized prospective clinical trial.

Authors:  Yaser Said Cetin; Omer Afsin Ozmen; Uygar Levent Demir; Fikret Kasapoglu; Oguz Basut; Hakan Coskun
Journal:  Pak J Med Sci       Date:  2018 May-Jun       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.